Forte Biosciences (FBRX)

• Market cap: $309M
• 1 day: -0.8%
• 5 days: -10.04%
• 1 month: -16.92%
• 3 months: -16.98%
• 6 months: 82.46%
• Year to date: 4.4%
• 1 year: 251.14%
• 5 years: -96.47%
• 10 years: -99.47%
• Sector: Healthcare
• Industry: Biotechnology

About: Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Employees: 16